Review



stemmacs pd0325901  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Miltenyi Biotec stemmacs pd0325901
    Stemmacs Pd0325901, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 29 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd0325901/StemMACS+PD0325901/custom%40130-103-923%4042069772
    Average 94 stars, based on 29 article reviews
    stemmacs pd0325901 - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: TBP regulates transposable element expression in early mouse embryos.
    Article Snippet: The pCMV6-Zfp740 (CAT#: MR200524), pCMV6-Zfp281 (CAT#: MR215383), pCMV6-Tcf7l2 (CAT#: MR224182), pCMV6Sox15 (CAT#: MR225149), pCMV6-Pknox1 (CAT#: MR222826), pCMV6-Obox1 (CAT#: MR223867), pCMV6-Obox2 (CAT#: MR219600), pCMV6-Obox3 (CAT#: MR224473), pCMV6-Obox5 (CAT#: MR202205), pCMV6-Obox6 (CAT#: MR215428), pCMV6Lhx8 (CAT#: MR226908), pCMV6-Klf7 (CAT#: MR204201), pCMV6-Hbp1 (CAT#: MR208277), pCMV6-Foxk1 (CAT#: MR222304), pCMV6-Bbx (CAT#: MR224547), pCMV6-Atf1 (CAT#: MR223254) were all purchased from OriGene. .. Mouse E14 ESC lines carrying the 2C:tbGFP-PEST (Nakatani et al, 2022) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with GlutaMAX (Gibco, 31966047) containing 15% fetal calf serum, NEAA (ThermoScientific, 11140-035), 2X leukemia inhibitory factor (LIF), penicillin–streptomycin (Gibco, 15070063), 0.1 mM 2-mercaptoethanol (ThermoScientific, 31350010), 3 μM CHIR99021 (Cayman, 13122-25) and 1 μM PD0325901 (Miltenyi, 130-106-541) on gelatin-coated plates at 37 °C in 5% CO2. ..

    Article Title: The role of ASS1 in mouse embryonic stem cell differentiation into mesendoderm lineages
    Article Snippet: .. Control mESCs (W2) and ASS1 -knockout mESCs (A26 and A27) were cultured under feeder-free conditions on fibronectin (1 mg/mL in PBS, Millipore) as attachment factor in 2i/LIF culture medium: PD0325901 (1 μM, Miltenyi Biotec), CHIR99021 (3 μM, Miltenyi Biotec) and leukemia inhibitory factor (1000 U/mL, Millipore) added into basic N2B27 medium including 50% DMEM/F12 (Gibco), 50% Neurobasal (Gibco), 1 × non-essential amino acids (NEAA, Gibco), 2 mM GlutaMax (Gibco), 1 × Penicillin/Streptomycin (Gibco), 0.1 mM β-mercaptoethanol (Gibco), 1% B27 (Gibco), 0.5% N2 (Gibco) supplemented with 50 mg/L BSA (Gibco). .. The mESCs usually are passaged regularly at every 2–3 days using StemPro Accutase (Life technology) as a cell dissociation agent.

    Article Title: The role of ASS1 in mouse embryonic stem cell differentiation into mesendoderm lineages.
    Article Snippet: .. Control mESCs (W2) and ASS1-knockout mESCs (A26 and A27) were cultured under feeder-free conditions on fibronectin (1 mg/mL in PBS, Millipore) as attachment factor in 2i/LIF culture medium: PD0325901 (1 μM, Miltenyi Biotec), CHIR99021 (3 μM, Miltenyi Biotec) and leukemia inhibitory factor (1000 U/mL, Millipore) added into basic N2B27 medium including 50% DMEM/F12 (Gibco), 50% Neurobasal (Gibco), 1 × nonessential amino acids (NEAA, Gibco), 2 mM GlutaMax (Gibco), 1 × Penicillin/Streptomycin (Gibco), 0.1 mM β-mercaptoethanol (Gibco), 1% B27 (Gibco), 0.5% N2 (Gibco) supplemented with 50 mg/L BSA (Gibco). .. The mESCs usually are passaged regularly at every 2–3 days using StemPro Accutase (Life technology) as a cell dissociation agent.

    Modification:

    Article Title: TBP regulates transposable element expression in early mouse embryos.
    Article Snippet: The pCMV6-Zfp740 (CAT#: MR200524), pCMV6-Zfp281 (CAT#: MR215383), pCMV6-Tcf7l2 (CAT#: MR224182), pCMV6Sox15 (CAT#: MR225149), pCMV6-Pknox1 (CAT#: MR222826), pCMV6-Obox1 (CAT#: MR223867), pCMV6-Obox2 (CAT#: MR219600), pCMV6-Obox3 (CAT#: MR224473), pCMV6-Obox5 (CAT#: MR202205), pCMV6-Obox6 (CAT#: MR215428), pCMV6Lhx8 (CAT#: MR226908), pCMV6-Klf7 (CAT#: MR204201), pCMV6-Hbp1 (CAT#: MR208277), pCMV6-Foxk1 (CAT#: MR222304), pCMV6-Bbx (CAT#: MR224547), pCMV6-Atf1 (CAT#: MR223254) were all purchased from OriGene. .. Mouse E14 ESC lines carrying the 2C:tbGFP-PEST (Nakatani et al, 2022) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with GlutaMAX (Gibco, 31966047) containing 15% fetal calf serum, NEAA (ThermoScientific, 11140-035), 2X leukemia inhibitory factor (LIF), penicillin–streptomycin (Gibco, 15070063), 0.1 mM 2-mercaptoethanol (ThermoScientific, 31350010), 3 μM CHIR99021 (Cayman, 13122-25) and 1 μM PD0325901 (Miltenyi, 130-106-541) on gelatin-coated plates at 37 °C in 5% CO2. ..

    other:

    Article Title: EpiFlow: multidimensional single-cell epigenetic profiling by spectral flow cytometry
    Article Snippet: To obtain the naive-pluripotent state, 1 μM PD0325901 (MEK inhibitor; StemMACS Miltenyi Biotec, 130-103-923) and 3 μM CHIR99021 (GSK3 inhibitor; StemMACS Miltenyi Biotec, 130-103-926) were added to the medium.

    Control:

    Article Title: The role of ASS1 in mouse embryonic stem cell differentiation into mesendoderm lineages
    Article Snippet: .. Control mESCs (W2) and ASS1 -knockout mESCs (A26 and A27) were cultured under feeder-free conditions on fibronectin (1 mg/mL in PBS, Millipore) as attachment factor in 2i/LIF culture medium: PD0325901 (1 μM, Miltenyi Biotec), CHIR99021 (3 μM, Miltenyi Biotec) and leukemia inhibitory factor (1000 U/mL, Millipore) added into basic N2B27 medium including 50% DMEM/F12 (Gibco), 50% Neurobasal (Gibco), 1 × non-essential amino acids (NEAA, Gibco), 2 mM GlutaMax (Gibco), 1 × Penicillin/Streptomycin (Gibco), 0.1 mM β-mercaptoethanol (Gibco), 1% B27 (Gibco), 0.5% N2 (Gibco) supplemented with 50 mg/L BSA (Gibco). .. The mESCs usually are passaged regularly at every 2–3 days using StemPro Accutase (Life technology) as a cell dissociation agent.

    Article Title: The role of ASS1 in mouse embryonic stem cell differentiation into mesendoderm lineages.
    Article Snippet: .. Control mESCs (W2) and ASS1-knockout mESCs (A26 and A27) were cultured under feeder-free conditions on fibronectin (1 mg/mL in PBS, Millipore) as attachment factor in 2i/LIF culture medium: PD0325901 (1 μM, Miltenyi Biotec), CHIR99021 (3 μM, Miltenyi Biotec) and leukemia inhibitory factor (1000 U/mL, Millipore) added into basic N2B27 medium including 50% DMEM/F12 (Gibco), 50% Neurobasal (Gibco), 1 × nonessential amino acids (NEAA, Gibco), 2 mM GlutaMax (Gibco), 1 × Penicillin/Streptomycin (Gibco), 0.1 mM β-mercaptoethanol (Gibco), 1% B27 (Gibco), 0.5% N2 (Gibco) supplemented with 50 mg/L BSA (Gibco). .. The mESCs usually are passaged regularly at every 2–3 days using StemPro Accutase (Life technology) as a cell dissociation agent.

    Knock-Out:

    Article Title: The role of ASS1 in mouse embryonic stem cell differentiation into mesendoderm lineages
    Article Snippet: .. Control mESCs (W2) and ASS1 -knockout mESCs (A26 and A27) were cultured under feeder-free conditions on fibronectin (1 mg/mL in PBS, Millipore) as attachment factor in 2i/LIF culture medium: PD0325901 (1 μM, Miltenyi Biotec), CHIR99021 (3 μM, Miltenyi Biotec) and leukemia inhibitory factor (1000 U/mL, Millipore) added into basic N2B27 medium including 50% DMEM/F12 (Gibco), 50% Neurobasal (Gibco), 1 × non-essential amino acids (NEAA, Gibco), 2 mM GlutaMax (Gibco), 1 × Penicillin/Streptomycin (Gibco), 0.1 mM β-mercaptoethanol (Gibco), 1% B27 (Gibco), 0.5% N2 (Gibco) supplemented with 50 mg/L BSA (Gibco). .. The mESCs usually are passaged regularly at every 2–3 days using StemPro Accutase (Life technology) as a cell dissociation agent.



    Similar Products

    stemmacs pd0325901  (Miltenyi Biotec)
    94
    Miltenyi Biotec stemmacs pd0325901
    Stemmacs Pd0325901, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd0325901/StemMACS+PD0325901/custom%40130-103-923%4042069772
    Average 94 stars, based on 1 article reviews
    stemmacs pd0325901 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    pd0325901  (TargetMol)
    95
    TargetMol pd0325901
    Pd0325901, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd0325901/Mirdametinib/pm42785310-319-22-23
    Average 95 stars, based on 1 article reviews
    pd0325901 - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    mirdametinib pd0325901  (MedChemExpress)
    94
    MedChemExpress mirdametinib pd0325901
    Mirdametinib Pd0325901, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd0325901/Mirdametinib/pm42478210-32-0-5
    Average 94 stars, based on 1 article reviews
    mirdametinib pd0325901 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    pd0325901  (MedChemExpress)
    96
    MedChemExpress pd0325901
    MEK/ERK promotes Fos expression and activation through both transcriptional regulation and post-translational modification ( A , B ) Prediction of upstream transcriptional regulators and construction of protein interaction networks for differentially expressed genes in metabolism-related pathways following treatment with BI ( A ) and PD ( B ) inhibitors. Node size is positively correlated with the network centrality (Degree value) of the gene. Node color from dark purple to light purple represents centrality from high to low. ( C , D ) RT-qPCR detection of Fos ( C ) and JUN ( D ) mRNA transcription levels after treatment with MEK/ERK inhibitors Binimetinib (BI) and <t>PD0325901</t> (PD). ( E ) Homology alignment and kinase prediction analysis of Fos protein phosphorylation sites between chicken ( Gallus gallus ) and human ( Homo sapiens ). The upper panel shows phosphorylation sites predicted by GPS 6.0, with human S362 and chicken S349 being high-confidence phosphorylation sites. The lower panel shows the results of MUSCLE multiple sequence alignment. The local short sequence containing S362/S349 is completely conserved between human and chicken species. The conserved phosphorylated serine (S) site is labeled in red. * indicates completely conserved amino acid residues. ( F ) Three-dimensional structural models of human and chicken Fos predicted by AlphaFold3 and visualized with PyMOL. Ser362 and Ser349 are located within the intrinsically disordered region and fully exposed on the protein surface. The left panel shows the full-length three-dimensional structure of Fos. The right panel provides an enlarged view of the region containing the phosphorylation site, highlighting the spatial positions of human Fos Ser362 and chicken Fos Ser349. ( G ) Western blot analysis of the effects of MEK/ERK inhibitor BI and PD treatment on total and phosphorylated protein levels of ERK1/2, Fos and JUN in uninfected cells and cells exposed to ILTV. Tubulin was used as a protein loading control. + and − indicate ILTV infection and mock treatment, respectively. Data in ( C , D ) are presented as mean ± SD, n = 3. Asterisks indicate statistical significance ( p < 0.05).
    Pd0325901, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd0325901/Mirdametinib/pmc13413502-68-26-27
    Average 96 stars, based on 1 article reviews
    pd0325901 - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    7ppm pd0325901  (TargetMol)
    95
    TargetMol 7ppm pd0325901
    MEK/ERK promotes Fos expression and activation through both transcriptional regulation and post-translational modification ( A , B ) Prediction of upstream transcriptional regulators and construction of protein interaction networks for differentially expressed genes in metabolism-related pathways following treatment with BI ( A ) and PD ( B ) inhibitors. Node size is positively correlated with the network centrality (Degree value) of the gene. Node color from dark purple to light purple represents centrality from high to low. ( C , D ) RT-qPCR detection of Fos ( C ) and JUN ( D ) mRNA transcription levels after treatment with MEK/ERK inhibitors Binimetinib (BI) and <t>PD0325901</t> (PD). ( E ) Homology alignment and kinase prediction analysis of Fos protein phosphorylation sites between chicken ( Gallus gallus ) and human ( Homo sapiens ). The upper panel shows phosphorylation sites predicted by GPS 6.0, with human S362 and chicken S349 being high-confidence phosphorylation sites. The lower panel shows the results of MUSCLE multiple sequence alignment. The local short sequence containing S362/S349 is completely conserved between human and chicken species. The conserved phosphorylated serine (S) site is labeled in red. * indicates completely conserved amino acid residues. ( F ) Three-dimensional structural models of human and chicken Fos predicted by AlphaFold3 and visualized with PyMOL. Ser362 and Ser349 are located within the intrinsically disordered region and fully exposed on the protein surface. The left panel shows the full-length three-dimensional structure of Fos. The right panel provides an enlarged view of the region containing the phosphorylation site, highlighting the spatial positions of human Fos Ser362 and chicken Fos Ser349. ( G ) Western blot analysis of the effects of MEK/ERK inhibitor BI and PD treatment on total and phosphorylated protein levels of ERK1/2, Fos and JUN in uninfected cells and cells exposed to ILTV. Tubulin was used as a protein loading control. + and − indicate ILTV infection and mock treatment, respectively. Data in ( C , D ) are presented as mean ± SD, n = 3. Asterisks indicate statistical significance ( p < 0.05).
    7ppm Pd0325901, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd0325901/Mirdametinib/bio_rxiv__64898__2026__07__02__736105-41-29-32
    Average 95 stars, based on 1 article reviews
    7ppm pd0325901 - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    pd0325901  (Miltenyi Biotec)
    94
    Miltenyi Biotec pd0325901
    MEK/ERK promotes Fos expression and activation through both transcriptional regulation and post-translational modification ( A , B ) Prediction of upstream transcriptional regulators and construction of protein interaction networks for differentially expressed genes in metabolism-related pathways following treatment with BI ( A ) and PD ( B ) inhibitors. Node size is positively correlated with the network centrality (Degree value) of the gene. Node color from dark purple to light purple represents centrality from high to low. ( C , D ) RT-qPCR detection of Fos ( C ) and JUN ( D ) mRNA transcription levels after treatment with MEK/ERK inhibitors Binimetinib (BI) and <t>PD0325901</t> (PD). ( E ) Homology alignment and kinase prediction analysis of Fos protein phosphorylation sites between chicken ( Gallus gallus ) and human ( Homo sapiens ). The upper panel shows phosphorylation sites predicted by GPS 6.0, with human S362 and chicken S349 being high-confidence phosphorylation sites. The lower panel shows the results of MUSCLE multiple sequence alignment. The local short sequence containing S362/S349 is completely conserved between human and chicken species. The conserved phosphorylated serine (S) site is labeled in red. * indicates completely conserved amino acid residues. ( F ) Three-dimensional structural models of human and chicken Fos predicted by AlphaFold3 and visualized with PyMOL. Ser362 and Ser349 are located within the intrinsically disordered region and fully exposed on the protein surface. The left panel shows the full-length three-dimensional structure of Fos. The right panel provides an enlarged view of the region containing the phosphorylation site, highlighting the spatial positions of human Fos Ser362 and chicken Fos Ser349. ( G ) Western blot analysis of the effects of MEK/ERK inhibitor BI and PD treatment on total and phosphorylated protein levels of ERK1/2, Fos and JUN in uninfected cells and cells exposed to ILTV. Tubulin was used as a protein loading control. + and − indicate ILTV infection and mock treatment, respectively. Data in ( C , D ) are presented as mean ± SD, n = 3. Asterisks indicate statistical significance ( p < 0.05).
    Pd0325901, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd0325901/StemMACS+PD0325901/pmc13108533-159-10-14
    Average 94 stars, based on 1 article reviews
    pd0325901 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    pd0325901  (Tocris)
    96
    Tocris pd0325901
    MEK/ERK promotes Fos expression and activation through both transcriptional regulation and post-translational modification ( A , B ) Prediction of upstream transcriptional regulators and construction of protein interaction networks for differentially expressed genes in metabolism-related pathways following treatment with BI ( A ) and PD ( B ) inhibitors. Node size is positively correlated with the network centrality (Degree value) of the gene. Node color from dark purple to light purple represents centrality from high to low. ( C , D ) RT-qPCR detection of Fos ( C ) and JUN ( D ) mRNA transcription levels after treatment with MEK/ERK inhibitors Binimetinib (BI) and <t>PD0325901</t> (PD). ( E ) Homology alignment and kinase prediction analysis of Fos protein phosphorylation sites between chicken ( Gallus gallus ) and human ( Homo sapiens ). The upper panel shows phosphorylation sites predicted by GPS 6.0, with human S362 and chicken S349 being high-confidence phosphorylation sites. The lower panel shows the results of MUSCLE multiple sequence alignment. The local short sequence containing S362/S349 is completely conserved between human and chicken species. The conserved phosphorylated serine (S) site is labeled in red. * indicates completely conserved amino acid residues. ( F ) Three-dimensional structural models of human and chicken Fos predicted by AlphaFold3 and visualized with PyMOL. Ser362 and Ser349 are located within the intrinsically disordered region and fully exposed on the protein surface. The left panel shows the full-length three-dimensional structure of Fos. The right panel provides an enlarged view of the region containing the phosphorylation site, highlighting the spatial positions of human Fos Ser362 and chicken Fos Ser349. ( G ) Western blot analysis of the effects of MEK/ERK inhibitor BI and PD treatment on total and phosphorylated protein levels of ERK1/2, Fos and JUN in uninfected cells and cells exposed to ILTV. Tubulin was used as a protein loading control. + and − indicate ILTV infection and mock treatment, respectively. Data in ( C , D ) are presented as mean ± SD, n = 3. Asterisks indicate statistical significance ( p < 0.05).
    Pd0325901, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pd0325901/PD+0325901/pmc13106735-417-38-39
    Average 96 stars, based on 1 article reviews
    pd0325901 - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    MEK/ERK promotes Fos expression and activation through both transcriptional regulation and post-translational modification ( A , B ) Prediction of upstream transcriptional regulators and construction of protein interaction networks for differentially expressed genes in metabolism-related pathways following treatment with BI ( A ) and PD ( B ) inhibitors. Node size is positively correlated with the network centrality (Degree value) of the gene. Node color from dark purple to light purple represents centrality from high to low. ( C , D ) RT-qPCR detection of Fos ( C ) and JUN ( D ) mRNA transcription levels after treatment with MEK/ERK inhibitors Binimetinib (BI) and PD0325901 (PD). ( E ) Homology alignment and kinase prediction analysis of Fos protein phosphorylation sites between chicken ( Gallus gallus ) and human ( Homo sapiens ). The upper panel shows phosphorylation sites predicted by GPS 6.0, with human S362 and chicken S349 being high-confidence phosphorylation sites. The lower panel shows the results of MUSCLE multiple sequence alignment. The local short sequence containing S362/S349 is completely conserved between human and chicken species. The conserved phosphorylated serine (S) site is labeled in red. * indicates completely conserved amino acid residues. ( F ) Three-dimensional structural models of human and chicken Fos predicted by AlphaFold3 and visualized with PyMOL. Ser362 and Ser349 are located within the intrinsically disordered region and fully exposed on the protein surface. The left panel shows the full-length three-dimensional structure of Fos. The right panel provides an enlarged view of the region containing the phosphorylation site, highlighting the spatial positions of human Fos Ser362 and chicken Fos Ser349. ( G ) Western blot analysis of the effects of MEK/ERK inhibitor BI and PD treatment on total and phosphorylated protein levels of ERK1/2, Fos and JUN in uninfected cells and cells exposed to ILTV. Tubulin was used as a protein loading control. + and − indicate ILTV infection and mock treatment, respectively. Data in ( C , D ) are presented as mean ± SD, n = 3. Asterisks indicate statistical significance ( p < 0.05).

    Journal: Microorganisms

    Article Title: MEK/ERK-Mediated Transcriptional Repression of Metabolic Genes Confers Host Defense Against Gallid alphaherpesvirus 1 Infection via Modulating Fos Nuclear Translocation

    doi: 10.3390/microorganisms14071492

    Figure Lengend Snippet: MEK/ERK promotes Fos expression and activation through both transcriptional regulation and post-translational modification ( A , B ) Prediction of upstream transcriptional regulators and construction of protein interaction networks for differentially expressed genes in metabolism-related pathways following treatment with BI ( A ) and PD ( B ) inhibitors. Node size is positively correlated with the network centrality (Degree value) of the gene. Node color from dark purple to light purple represents centrality from high to low. ( C , D ) RT-qPCR detection of Fos ( C ) and JUN ( D ) mRNA transcription levels after treatment with MEK/ERK inhibitors Binimetinib (BI) and PD0325901 (PD). ( E ) Homology alignment and kinase prediction analysis of Fos protein phosphorylation sites between chicken ( Gallus gallus ) and human ( Homo sapiens ). The upper panel shows phosphorylation sites predicted by GPS 6.0, with human S362 and chicken S349 being high-confidence phosphorylation sites. The lower panel shows the results of MUSCLE multiple sequence alignment. The local short sequence containing S362/S349 is completely conserved between human and chicken species. The conserved phosphorylated serine (S) site is labeled in red. * indicates completely conserved amino acid residues. ( F ) Three-dimensional structural models of human and chicken Fos predicted by AlphaFold3 and visualized with PyMOL. Ser362 and Ser349 are located within the intrinsically disordered region and fully exposed on the protein surface. The left panel shows the full-length three-dimensional structure of Fos. The right panel provides an enlarged view of the region containing the phosphorylation site, highlighting the spatial positions of human Fos Ser362 and chicken Fos Ser349. ( G ) Western blot analysis of the effects of MEK/ERK inhibitor BI and PD treatment on total and phosphorylated protein levels of ERK1/2, Fos and JUN in uninfected cells and cells exposed to ILTV. Tubulin was used as a protein loading control. + and − indicate ILTV infection and mock treatment, respectively. Data in ( C , D ) are presented as mean ± SD, n = 3. Asterisks indicate statistical significance ( p < 0.05).

    Article Snippet: Two highly selective MEK1/2 inhibitors were used in this study, with the following working concentrations: Binimetinib (MCE, HY-15202, Monmouth Junction, NJ, USA) at 1 μM, and PD0325901 (MCE, HY-10254, Monmouth Junction, NJ, USA) at 0.25 μM.

    Techniques: Expressing, Activation Assay, Modification, Quantitative RT-PCR, Phospho-proteomics, Sequencing, Labeling, Western Blot, Control, Infection

    The MEK/ERK pathway regulates Fos subcellular localization by promoting Fos phosphorylation ( A ) Nuclear-cytoplasmic fractionation combined with Western blot detection of the effects of MEK/ERK inhibitor treatment on the expression levels of phosphorylated Fos (p-Fos Ser362) and total Fos protein in cytoplasm and nucleus of uninfected/ILTV-infected cells. HSP90 was used as a cytoplasm-specific internal reference. Lamin B was used as a nucleus-specific internal reference. Tubulin was used as a whole-cell protein loading internal reference. DMSO was used as the solvent control. BI was the Binimetinib inhibitor group. PD was the PD0325901 inhibitor group. ( B ) Indirect immunofluorescence staining combined with laser confocal microscopy observation of the effects of MEK/ERK inhibitor treatment on p-Fos subcellular localization and expression. Upper panel: representative images showing p-Fos (FITC, green), nuclei (DAPI, blue) and merged fluorescence signals. Scale bar, 20 μm. Lower panel: quantitative analysis of the p-Fos nuclear translocation ratio (n ≥ 50 cells per group). * indicates statistically significant difference between groups ( p < 0.05).

    Journal: Microorganisms

    Article Title: MEK/ERK-Mediated Transcriptional Repression of Metabolic Genes Confers Host Defense Against Gallid alphaherpesvirus 1 Infection via Modulating Fos Nuclear Translocation

    doi: 10.3390/microorganisms14071492

    Figure Lengend Snippet: The MEK/ERK pathway regulates Fos subcellular localization by promoting Fos phosphorylation ( A ) Nuclear-cytoplasmic fractionation combined with Western blot detection of the effects of MEK/ERK inhibitor treatment on the expression levels of phosphorylated Fos (p-Fos Ser362) and total Fos protein in cytoplasm and nucleus of uninfected/ILTV-infected cells. HSP90 was used as a cytoplasm-specific internal reference. Lamin B was used as a nucleus-specific internal reference. Tubulin was used as a whole-cell protein loading internal reference. DMSO was used as the solvent control. BI was the Binimetinib inhibitor group. PD was the PD0325901 inhibitor group. ( B ) Indirect immunofluorescence staining combined with laser confocal microscopy observation of the effects of MEK/ERK inhibitor treatment on p-Fos subcellular localization and expression. Upper panel: representative images showing p-Fos (FITC, green), nuclei (DAPI, blue) and merged fluorescence signals. Scale bar, 20 μm. Lower panel: quantitative analysis of the p-Fos nuclear translocation ratio (n ≥ 50 cells per group). * indicates statistically significant difference between groups ( p < 0.05).

    Article Snippet: Two highly selective MEK1/2 inhibitors were used in this study, with the following working concentrations: Binimetinib (MCE, HY-15202, Monmouth Junction, NJ, USA) at 1 μM, and PD0325901 (MCE, HY-10254, Monmouth Junction, NJ, USA) at 0.25 μM.

    Techniques: Phospho-proteomics, Fractionation, Western Blot, Expressing, Infection, Solvent, Control, Immunofluorescence, Staining, Confocal Microscopy, Fluorescence, Translocation Assay

    Fos acts as a core direct transcriptional repressor of metabolic genes downstream of the MEK/ERK pathway ( A ) Clustering heatmap showing the expression profile of differentially expressed metabolism-related genes in host cells after treatment with MEK/ERK inhibitors Binimetinib (BI) and PD0325901 (PD). Red indicates upregulated genes, and blue indicates downregulated genes. ( B ) PPI network analysis of differentially expressed metabolism-related genes. Node size is positively correlated with the network centrality (Degree value) of the gene. Node color from dark purple to light purple represents centrality from high to low. ( C ) RT-qPCR detection of Fos-specific siRNA knockdown efficiency. ( D ) Western blot detection of the expression efficiency of HA-tagged Fos overexpression vector. Tubulin was used as the protein loading control. ( E ) RT-qPCR detection of the effects of Fos knockdown/overexpression on the transcription levels of six core metabolic genes. ( F ) RT-qPCR detection of the effects of Fos knockdown on the transcription levels of six core metabolic genes under ILTV infection conditions. ( G ) ChIP-qPCR detection of Fos binding to the promoter regions of six core metabolic genes, with isotype control IgG as the negative control. Data in ( C , E – G ) are expressed as mean ± SD. n = 3. * indicates statistically significant difference between groups ( p < 0.05). ns indicates no statistically significant difference.

    Journal: Microorganisms

    Article Title: MEK/ERK-Mediated Transcriptional Repression of Metabolic Genes Confers Host Defense Against Gallid alphaherpesvirus 1 Infection via Modulating Fos Nuclear Translocation

    doi: 10.3390/microorganisms14071492

    Figure Lengend Snippet: Fos acts as a core direct transcriptional repressor of metabolic genes downstream of the MEK/ERK pathway ( A ) Clustering heatmap showing the expression profile of differentially expressed metabolism-related genes in host cells after treatment with MEK/ERK inhibitors Binimetinib (BI) and PD0325901 (PD). Red indicates upregulated genes, and blue indicates downregulated genes. ( B ) PPI network analysis of differentially expressed metabolism-related genes. Node size is positively correlated with the network centrality (Degree value) of the gene. Node color from dark purple to light purple represents centrality from high to low. ( C ) RT-qPCR detection of Fos-specific siRNA knockdown efficiency. ( D ) Western blot detection of the expression efficiency of HA-tagged Fos overexpression vector. Tubulin was used as the protein loading control. ( E ) RT-qPCR detection of the effects of Fos knockdown/overexpression on the transcription levels of six core metabolic genes. ( F ) RT-qPCR detection of the effects of Fos knockdown on the transcription levels of six core metabolic genes under ILTV infection conditions. ( G ) ChIP-qPCR detection of Fos binding to the promoter regions of six core metabolic genes, with isotype control IgG as the negative control. Data in ( C , E – G ) are expressed as mean ± SD. n = 3. * indicates statistically significant difference between groups ( p < 0.05). ns indicates no statistically significant difference.

    Article Snippet: Two highly selective MEK1/2 inhibitors were used in this study, with the following working concentrations: Binimetinib (MCE, HY-15202, Monmouth Junction, NJ, USA) at 1 μM, and PD0325901 (MCE, HY-10254, Monmouth Junction, NJ, USA) at 0.25 μM.

    Techniques: Expressing, Quantitative RT-PCR, Knockdown, Western Blot, Over Expression, Plasmid Preparation, Control, Infection, ChIP-qPCR, Binding Assay, Negative Control